135 related articles for article (PubMed ID: 27489039)
1. An all-atom, active site exploration of antiviral drugs that target Flaviviridae polymerases.
Valdés JJ; Gil VA; Butterill PT; Růžek D
J Gen Virol; 2016 Oct; 97(10):2552-2565. PubMed ID: 27489039
[TBL] [Abstract][Full Text] [Related]
2. Flaviviridae viruses use a common molecular mechanism to escape nucleoside analogue inhibitors.
Valdés JJ; Butterill PT; Růžek D
Biochem Biophys Res Commun; 2017 Oct; 492(4):652-658. PubMed ID: 28322784
[TBL] [Abstract][Full Text] [Related]
3. A Structural Overview of RNA-Dependent RNA Polymerases from the Flaviviridae Family.
Wu J; Liu W; Gong P
Int J Mol Sci; 2015 Jun; 16(6):12943-57. PubMed ID: 26062131
[TBL] [Abstract][Full Text] [Related]
4. RNA-dependent RNA polymerases from Flaviviridae.
Choi KH; Rossmann MG
Curr Opin Struct Biol; 2009 Dec; 19(6):746-51. PubMed ID: 19914821
[TBL] [Abstract][Full Text] [Related]
5. Rational design of polymerase inhibitors as antiviral drugs.
Oberg B
Antiviral Res; 2006 Sep; 71(2-3):90-5. PubMed ID: 16820225
[TBL] [Abstract][Full Text] [Related]
6. Current approaches in antiviral drug discovery against the Flaviviridae family.
Baharuddin A; Hassan AA; Sheng GC; Nasir SB; Othman S; Yusof R; Othman R; Rahman NA
Curr Pharm Des; 2014; 20(21):3428-44. PubMed ID: 24001228
[TBL] [Abstract][Full Text] [Related]
7. An updated evolutionary study of Flaviviridae NS3 helicase and NS5 RNA-dependent RNA polymerase reveals novel invariable motifs as potential pharmacological targets.
Papageorgiou L; Loukatou S; Sofia K; Maroulis D; Vlachakis D
Mol Biosyst; 2016 Jun; 12(7):2080-93. PubMed ID: 26864387
[TBL] [Abstract][Full Text] [Related]
8. Computational predictions suggest that structural similarity in viral polymerases may lead to comparable allosteric binding sites.
Brown JA; Espiritu MV; Abraham J; Thorpe IF
Virus Res; 2016 Aug; 222():80-93. PubMed ID: 27262620
[TBL] [Abstract][Full Text] [Related]
9. The antiviral activity and mechanism of action of (S)-[3-hydroxy-2-(phosphonomethoxy)propyl] (HPMP) nucleosides.
Magee WC; Evans DH
Antiviral Res; 2012 Nov; 96(2):169-80. PubMed ID: 22960154
[TBL] [Abstract][Full Text] [Related]
10. Sofosbuvir as treatment against dengue?
Gan CS; Lim SK; Chee CF; Yusof R; Heh CH
Chem Biol Drug Des; 2018 Feb; 91(2):448-455. PubMed ID: 28834304
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of ATP-binding site directed potential inhibitors of nucleoside triphosphatases/helicases and polymerases of hepatitis C and other selected Flaviviridae viruses.
Bretner M; Schalinski S; Haag A; Lang M; Schmitz H; Baier A; Behrens SE; Kulikowski T; Borowski P
Antivir Chem Chemother; 2004 Jan; 15(1):35-42. PubMed ID: 15074713
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of NTP Binding to the Active Site of T7 RNA Polymerase Revealed by Free-Energy Simulation.
Wu S; Li L; Li Q
Biophys J; 2017 Jun; 112(11):2253-2260. PubMed ID: 28591598
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a potent respiratory syncytial virus RNA polymerase inhibitor.
Xiong H; Foulk M; Aschenbrenner L; Fan J; Tiong-Yip CL; Johnson KD; Moustakas D; Fleming PR; Brown DG; Zhang M; Ferguson D; Wu D; Yu Q
Bioorg Med Chem Lett; 2013 Dec; 23(24):6789-93. PubMed ID: 24211022
[TBL] [Abstract][Full Text] [Related]
14. In silico prediction of ebolavirus RNA polymerase inhibition by specific combinations of approved nucleotide analogues.
van Hemert FJ; Zaaijer HL; Berkhout B
J Clin Virol; 2015 Dec; 73():89-94. PubMed ID: 26587786
[TBL] [Abstract][Full Text] [Related]
15. The fight against the influenza A virus H1N1: synthesis, molecular modeling, and biological evaluation of benzofurazan derivatives as viral RNA polymerase inhibitors.
Pagano M; Castagnolo D; Bernardini M; Fallacara AL; Laurenzana I; Deodato D; Kessler U; Pilger B; Stergiou L; Strunze S; Tintori C; Botta M
ChemMedChem; 2014 Jan; 9(1):129-50. PubMed ID: 24285596
[TBL] [Abstract][Full Text] [Related]
16. Identification of a T7 RNA polymerase variant that permits the enzymatic synthesis of fully 2'-O-methyl-modified RNA.
Ibach J; Dietrich L; Koopmans KR; Nöbel N; Skoupi M; Brakmann S
J Biotechnol; 2013 Sep; 167(3):287-95. PubMed ID: 23871655
[TBL] [Abstract][Full Text] [Related]
17. Biochemical characterization of the inhibition of the dengue virus RNA polymerase by beta-d-2'-ethynyl-7-deaza-adenosine triphosphate.
Latour DR; Jekle A; Javanbakht H; Henningsen R; Gee P; Lee I; Tran P; Ren S; Kutach AK; Harris SF; Wang SM; Lok SJ; Shaw D; Li J; Heilek G; Klumpp K; Swinney DC; Deval J
Antiviral Res; 2010 Aug; 87(2):213-22. PubMed ID: 20470829
[TBL] [Abstract][Full Text] [Related]
18. A conformational mimetic approach for the synthesis of carbocyclic nucleosides as anti-HCV leads.
Kasula M; Balaraju T; Toyama M; Thiyagarajan A; Bal C; Baba M; Sharon A
ChemMedChem; 2013 Oct; 8(10):1673-80. PubMed ID: 23943612
[TBL] [Abstract][Full Text] [Related]
19. Activity of Mannich bases of 7-hydroxycoumarin against Flaviviridae.
Mazzei M; Nieddu E; Miele M; Balbi A; Ferrone M; Fermeglia M; Mazzei MT; Pricl S; La Colla P; Marongiu F; Ibba C; Loddo R
Bioorg Med Chem; 2008 Mar; 16(5):2591-605. PubMed ID: 18054491
[TBL] [Abstract][Full Text] [Related]
20. A computational approach for predicting off-target toxicity of antiviral ribonucleoside analogues to mitochondrial RNA polymerase.
Freedman H; Winter P; Tuszynski J; Tyrrell DL; Houghton M
J Biol Chem; 2018 Jun; 293(25):9696-9705. PubMed ID: 29739852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
